Close Menu

NEW YORK (GenomeWeb) – Caribou Biosciences today announced that it has closed an $11 million Series A financing round.

Investors included Fidelity Biosciences, Novartis, Mission Bay Capital, 5 Prime Ventures, and one undisclosed partner. Caribou co-founder and pioneering CRISPR/Cas9 researcher Jennifer Doudna has also joined as an investor, the firm said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Oregon state Senate unanimously passed a bill that would make it easier for people convicted of crimes to initiate DNA testing of evidence, according to the Associated Press.

People reports that researchers have uncovered genetic variants that lead people to always feel full.

Florida state senators are to weigh a bill prohibiting life insurance companies from using genetic information in coverage decisions, according to Florida Politics.

In Genome Research this week: metagenomic sequencing assay that detects pathogens in cerebrospinal fluid, single-tube long fragment read approach, and more.